- Home
- PSTV vs INMB Comparison
PSTV vs INMB Comparison
Compare PSTV & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PSTV | INMB |
|---|---|---|
| Founded | 1996 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.2M | 37.2M |
| IPO Year | 2016 | 2018 |
Fundamental Metrics
Financial Performance| Metric | PSTV | INMB |
|---|---|---|
| Price | $5.21 | $1.28 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 5 |
| Target Price | ★ $55.00 | $5.40 |
| AVG Volume (30 Days) | 130.2K | ★ 462.1K |
| Earning Date | 05-29-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 87.61 | 11.85 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $5,213,000.00 | $50,000.00 |
| Revenue This Year | $13.20 | N/A |
| Revenue Next Year | $261.48 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 257.14 |
| 52 Week Low | $0.13 | $1.09 |
| 52 Week High | $8.00 | $11.64 |
Technical Indicators
Market Signals| Indicator | PSTV | INMB |
|---|---|---|
| Relative Strength Index (RSI) | 42.17 | 43.37 |
| Support Level | $0.37 | $1.15 |
| Resistance Level | $6.65 | $1.52 |
| Average True Range (ATR) | 0.47 | 0.08 |
| MACD | -0.14 | -0.02 |
| Stochastic Oscillator | 3.45 | 23.73 |
Price Performance
Historical ComparisonAbout PSTV PLUS THERAPEUTICS Inc.
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, commercializing and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).
About INMB INmune Bio Inc.
INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.